ClinicalTrials.Veeva

Menu

Evaluation of Diabetes Care at Austrian GPs (DCA09)

AstraZeneca logo

AstraZeneca

Status

Terminated

Conditions

Type 2 Diabetes

Study type

Observational

Funder types

Industry

Identifiers

NCT00979394
NIS-CAT-DUM-2009/1

Details and patient eligibility

About

This registery should show the medical care of patient with Type 2 Diabetes (T2D) at GP-offices. Furthermore data of co morbidities and risk factors should be evaluated. Objectives of this NIS (cross-sectional study) are:

  • To evaluate which characteristics or co-morbidities are being existent for patient with T2D at GP level,
  • To evaluate representative profile of patient with T2D in Austria,
  • To evaluate which medical therapies are used.

Enrollment

1,513 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diabetes mellitus type II

Exclusion criteria

  • Diabetes mellitus type I
  • Gestation diabetes
  • Induced diabetes

Trial design

1,513 participants in 1 patient group

Patients with type 2 diabetes

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems